Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy
This is a study for women with iron deficiency anemia receiving prenatal care at Banner University Medical Center OBGYN. Eligible participants will be randomized to receive either oral iron therapy or intravenous iron infusions.
Study phase: Other
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
Pregnant women 18 years of age or older.
Singleton gestation (no twins ect).
Between 20 and 37 weeks pregnant
Primary disease category: Women's Health
Sponsor: amag Pharmaceuticals
Projected enrollment dates: November 2017 to December 2019
Official study title: Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: A randomized controlled trial